Eosinophilia Associated Neoplasms Flashcards

1
Q

What doe PDGFR A/B mean?

A

Platelet derived growth factor A and B.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the categories of myeloid/lymphoid neoplasms with eosinophilia?

A

They are categorised into those with:
PDGFRA, PDGFRB and FGFR1 rearrangements,
(PCM1-JAK2 rearrangements are a provisional entry).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the most common rearrangement seen in myeloid/lymphoid neoplasms with PDGFRA?
What causes the pathogenicity of it? How do we detect it?

A

A deletion of CHIC2 - it isn’t visible cytogenetically, it is cryptic.

This lies between PDGFRA and FIP1L1 and it’s deletion fuses these 2 proto-oncogenes.

We have a FISH probe that can detect this cryptic deletion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What else can cause myeloid/lymphoid neoplasms with PDGFRA rearrangement?

A

Translocations which involve 4q12 and fuse PDGFRA with another gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the most common cause of myeloid/lymphoid neoplasms with PDGFRB?

A

A t(5;12) translocation that rearranges ETV6 with PDGFRB.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Where is PDGFRB located?

A

5q31~33

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the other causes of myeloid/lymphoid neoplasms with PDGFRB?

A

There are other rearrangements involving PDGFRB but all are cytogenetically visible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What can neoplasms with PDGFRA or PDGFRB be treated with? What is the prognosis?
What about when treatment resistant mutations are present?

A

They respond really well to imatinib.
Prognosis is therefore good.
Resistance mutations are rare but tend to respond to alternatives such as dasatinib.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If we get an AML with eosinophilia and all tests are normal (AML FISH and karyotype) what additional testing should we consider?

A

FISH for PDGFRA-FIP1L1 - cryptic rearrangement so important to eliminate.

Other relevant rearrangements would be visible and delete by karyotype.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Where is FGFR1?

A

8p11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the most common rearrangement associated with FGFR1?

A

t(8;13)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the prognosis associated with FGFR1? Does this disease respond to imatinib?

A

Associated with a poor prognosis and aggressive disease.

Does not respond to imatinib.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the myeloid/lymphoid neoplasms with PDGFRA/B and FGFR1 driven diseases at risk of transforming into?

A

They can transform into either myeloid or lymphoid leukaemia dependant on additional driving mutations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly